Literature DB >> 19626579

Malaria in pregnant woman masquerading as HELLP syndrome.

Guillaume Ducarme1, Claire Thuillier, Anne Wernet, Claire Bellier, Dominique Luton.   

Abstract

Malaria may be complicated by development of thrombocytopenia, elevated liver enzymes, and/or hemolysis, which may be difficult to distinguish from HELLP (hemolytic anemia; elevated liver enzymes; low platelet count) syndrome in a pregnant patient. A 33-year-old woman developed a HELLP-like syndrome and persistent fever postpartum without symptoms of preeclampsia. A malaria blood smear was performed and was positive for Plasmodium falciparum. The patient was immediately treated with quinine. The follow-up was uneventful with total disappearance of fever and prompt resolution of biochemical signs of HELLP-like syndrome 3 days later. Malaria in a pregnant woman can masquerade as HELLP syndrome. The wide overlap in symptoms (headache, malaise, digestive symptoms) does not suggest that symptoms would be effective in differentiating malaria and preeclampsia. A recent travel in endemic area, associated with malaria blood smear and clinic examination, should be the key of the differential diagnosis. Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626579     DOI: 10.1055/s-0029-1234035

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

1.  Malaria and pregnancy: a global health perspective.

Authors:  Julianna Schantz-Dunn; Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2009

2.  Development of severe pathology in immunized pregnant mice challenged with lethal malaria parasites.

Authors:  Shoichiro Mineo; Mamoru Niikura; Shin-Ichi Inoue; Masahiko Kuroda; Fumie Kobayashi
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

3.  The association between acute fatty liver disease and nitric oxide during malaria in pregnancy.

Authors:  Mamoru Niikura; Toshiyuki Fukutomi; Shoichiro Mineo; Jiro Mitobe; Fumie Kobayashi
Journal:  Malar J       Date:  2021-12-14       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.